Press Releases | Medtronic

Month Year

Email alerts

Jul 15, 2020

Medtronic to Acquire Medicrea

Medtronic Will Become the First Company to Offer an Integrated Solution Including Artificial Intelligence-Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted Surgery

DUBLIN and LYON, France, July 15, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader in medical technology, and Medicrea (Euronext Growth Paris: FR0004178572 – ALMED Medicrea;...
Jun 25, 2020

FDA Approves First-Of-Its-Kind Percept™ PC Neurostimulator with BrainSense™ Technology

Next-Generation Technology Makes Percept™ the First and Only DBS System with Ability to Capture Patient-Specific Brain Signals

DUBLIN, June 25, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announces it received Food and Drug Administration (FDA) approval for the...
Feb 25, 2020

Medtronic EVP & RTG President Brett Wall to Speak at Cowen Healthcare Conference

DUBLIN, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 40th Annual Cowen and Company Healthcare...
Feb 13, 2020

Medtronic to Advance Solutions and Capabilities in Surgical Data and Analytics with Acquisition of Digital Surgery

Acquisition Will Accelerate Medtronic’s Strategy to Provide AI and Data Within Laparoscopic and Robotic Assisted Surgery

DUBLIN, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the acquisition of Digital Surgery, a privately-held pioneer in...
Jan 23, 2020

Medtronic Launches Efficio™ Software to Help Clinicians Efficiently Manage Targeted Drug Delivery Therapy with SynchroMed™ II

Efficio Software Provides Enhanced, Secure Access to Patient Data and Delivers

DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the launch of Efficio™, a cloud-based data management software for use with the SynchroMed™ II intrathecal...
Jan 21, 2020

DTM™ Spinal Cord Stimulation Using the Medtronic Intellis™ Platform Shows Superior Back Pain Relief Compared to Conventional SCS Therapy in an RCT

At Three-Months, 80% of Patients Treated with DTM SCS Reported Back Pain Relief of at Least 50%; 63% Reported Profound Back Pain Relief of 80% or Greater1

DUBLIN, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced three-month results from a large, multicenter randomized controlled trial (RCT) showing statistically significant...
Jan 16, 2020

Phoenix Children’s Is the First-Ever Health System in the U.S to Use Medtronic Stealth Autoguide™ Cranial Robotic Guidance Platform for Neurosurgery

Pediatric Health System First to Use Groundbreaking Cranial Robotic System in a Patient Surgery

DUBLIN and PHOENIX, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Nationally ranked pediatric leader, Phoenix Children’s Hospital, is the first-ever health system in the U.S. to receive and deploy the newly...
Jan 13, 2020

Medtronic Receives CE Mark for InterStim™ Micro Neurostimulator and InterStim™ SureScan™ MRI Leads

Full-Body MRI-Conditional InterStim II and InterStim Micro Systems Offer Lifestyle-Friendly Choices in Sacral Neuromodulation Therapy to Europeans Suffering from Incontinence

DUBLIN, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received CE Mark for its InterStim™ Micro neurostimulator and InterStim™ SureScan™ MRI leads —...
Jan 9, 2020

Medtronic Receives CE Mark Approval for the Percept™ PC Neurostimulator DBS System with BrainSense™ Technology

This Next-Generation DBS Technology Allows Physicians to Review Patient-Specific Brain Signals, Enabling More Personalized, Data-Driven Neurostimulation Treatment for Patients

DUBLIN, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the CE (Conformité Européenne) Mark for Percept™ PC neurostimulator; it is the only Deep Brain Stimulation...
Jan 8, 2020

Medtronic Acquires Stimgenics, Pioneer of DTM™, a Novel Spinal Cord Stimulation Therapy

Randomized Control Trial Results to be Presented at NANS Jan. 23-26 in Las Vegas; New, Proprietary Differential Target Multiplexed (DTM) Therapy Available on Medtronic Intellis Spinal Cord Stimulation Platform

DUBLIN, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced it has acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has pioneered a novel...

Show per page